HeartSciences Inc. HSCS
3.10 USD +0.15 (+5.08%)
At closeNov 4, 2026, 4:00 PM EST
3.10 0.00 0.00%
After hours · Nov 4, 4:00 PM ET
3.02 Day range 3.26
1.63 52-week range 5.25
- YTD
- +0.32%
- 1 year
- +9.54%
Financial health
Altman Z-Score
-41.49 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
1 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C2 / 5 overall
- DCF 1
- Return on Equity 5
- Return on Assets 1
- Debt / Equity 1
- P/E 1
- P/B 1
Valuation
P/E -0.6×
FY 2020 5y median -0.6× FY 2026
P/S 1185×
FY 2020 5y median 757× FY 2026
P/B 0.0×
FY 2020 5y median 0.4× FY 2026
P/FCF -0.7×
FY 2020 5y median -0.7× FY 2026
EV/EBITDA -276×
FY 2020 5y median -1.1× FY 2026
EV/Sales 529047×
FY 2020 5y median 1191× FY 2026
FCF Yield -145.9%
FY 2020 5y median -145.9% FY 2026
Profitability
Gross Margin -2982.1%
FY 2020 5y median -476.9% FY 2026
Operating Margin -194787.4%
FY 2020 5y median -118698.3% FY 2026
Net Margin -211666.5%
FY 2020 5y median -123384.3% FY 2026
ROE -4.1%
FY 2020 5y median -90.3% FY 2026
ROIC -0.2%
FY 2020 5y median -261.8% FY 2026
ROA -0.2%
FY 2020 5y median -193.3% FY 2026
Growth (YoY)
Revenue -0.7%
FY 2020 FY 2026
Operating Income -0.7%
FY 2020 FY 2026
EPS (diluted) 62.7%
FY 2020 FY 2026
Free Cash Flow -0.4%
FY 2020 FY 2026
Financial Health
Current Ratio 0.5×
FY 2020 5y median 0.6× FY 2026
Quick Ratio 0.4×
FY 2020 5y median 0.4× FY 2026
Debt / Equity 17.5×
FY 2020 5y median 6.8× FY 2026
Net Debt / EBITDA -275×
FY 2020 5y median -0.2× FY 2026
Interest Coverage -11.2×
FY 2020 5y median -16.7× FY 2026
Dividends
Dividend Yield 0.0%
FY 2020 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2020 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-04-30